An australian audit of vaccination status in children and adolescents with inflammatory bowel disease

Crawford, Nigel; Catto‐Smith, Anthony G.; Oliver, Mark; Cameron, Donald J. S.; Buttery, Jim

doi:10.1186/1471-230x-11-87

Cited by 35 publications

(25 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All previously published studies assessing the seasonal influenza vaccination coverage in patients with IBD emphasised that the rates of influenza vaccination were low and varied from 19%13 to 28% in adults7,14 and that this rate was only 10% in children 10. However, the vaccination rate in our study was <8%.…”

Section: Discussioncontrasting

confidence: 67%

“…However, none of these studies had a control arm, and all but one study was performed in adult patients 7–9. The only paediatric study in patients with IBD was an Australian audit that reviewed medical records 10. In Australia, the annual influenza immunisation is funded for special risk groups, such as children and adolescents with IBD who are ≥6 months of age.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Influenza vaccination coverage in children with inflammatory bowel disease

Banaszkiewicz

Klincewicz

Łazowska-Przeorek

et al. 2014

Influenza Resp Viruses

View full text Add to dashboard Cite

The aim of this study was to evaluate the influenza vaccination status among paediatric patients with inflammatory bowel disease (IBD) in Poland. This was a questionnaire-based study. 242 patients with IBD and 142 controls were enrolled in the study. Of patients with IBD, 7·8% received an influenza vaccine, compared to 18·3% of controls (P = 0·0013). There were no statistically significant differences in time from IBD diagnosis, disease activity and in drugs, between vaccinated and non-vaccinated IBD children. In conclusion, the data of our study demonstrate an alarmingly poor influenza vaccination status in the majority of children with IBD. Therefore, there is an unmet need to implement better influenza vaccination strategies for this group of patients.

show abstract

Section: Discussioncontrasting

confidence: 67%

Section: Introductionmentioning

confidence: 99%

Influenza vaccination coverage in children with inflammatory bowel disease

Banaszkiewicz

Klincewicz

Łazowska-Przeorek

et al. 2014

Influenza Resp Viruses

View full text Add to dashboard Cite

show abstract

“…Several studies have demonstrated that the most patients with IBD do not receive adequate vaccinations across multiple diff erent healthcare settings ( 7,14,(32)(33)(34)(35)(36)(37)(38)(39)(40). Th is seems to refl ect defi ciencies in provider knowledge both from gastroenterologists and primary care practitioners ( 6,8,41 ).…”

Section: Summary Of Evidencementioning

confidence: 99%

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease

Farraye

Melmed

Lichtenstein

et al. 2017

American Journal of Gastroenterology

403

421

View full text Add to dashboard Cite

Recent data suggest that infl ammatory bowel disease (IBD) patients do not receive preventive services at the same rate as general medical patients. Patients with IBD often consider their gastroenterologist to be the primary provider of care. To improve the care delivered to IBD patients, health maintenance issues need to be co-managed by both the gastroenterologist and primary care team. Gastroenterologists need to explicitly inform the primary care provider of the unique needs of the IBD patient, especially those on immunomodulators and biologics or being considered for such therapy. In particular, documentation of up to date vaccinations are crucial as IBD patients are often treated with long-term immune-suppressive therapies and may be at increased risk for infections, many of which are preventable with vaccinations. Health maintenance issues addressed in this guideline include identifi cation, safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, melanoma and non-melanoma skin cancer as well as identifi cation of depression and anxiety and smoking cessation. To accomplish these health maintenance goals, coordination between the primary care provider, gastroenterology team and other specialists is necessary. of evidence, we entered data from the papers of highest evidence into the GRADE program (accessible at http://www.gradepro.org ). Th e recommendation statements from this guideline are shown in Table 1 . Summary statements, when listed, are designed to be descriptive in nature without associated evidence-based ratings. VACCINATIONSRecent data suggest that IBD patients do not receive preventive services at the same rate as general medical patients ( 2 ). Members of the gastroenterology team are oft en the only clinicians that a patient with IBD will see. As such, it is incumbent upon gastroenterologists to take a proactive role in the health care needs of their IBD patients ( 3-5 ). It is crucial to clarify with the patient the limits of the specialist's responsibilities and delegate routine health care issues to the primary care clinician. It is equally important to educate the primary care clinician to the unique health maintenance needs of the IBD patient, especially those on immunomodulators and biologic agents. Although it appears that both primary care clinicians and gastroenterologists are hesitant to take ownership of vaccinations ( 6-8 ), it is reasonable ( 9 ) that vaccination recommendations be the responsibility of the treating gastroenterologist, but the actual delivery/administration of these vaccines may be a shared responsibility ( 10-13 ). Communicating specifi c recommendations to the primary care team in a concise fashion are needed. Consider empowering the patient by giving written recommendations to bring to their primary care physician. Clinicians sharing an electronic medical record should use this platform to send recommendations to the referring clinician.Patients with IBD are oft en treated with long-term immunesuppressive therapies and may t...

show abstract

“…Two of these studies were retrospective and did not include a control group [36,37]. An Australian study was based on the review of medical records of a random sample of IBD patients (n = 101) [36].…”

Section: Vaccine Coverage In Children With Ibdmentioning

confidence: 99%